D.A. Davidson & Co’s Immunome IMNM Stock Holding History

D.A. Davidson & Co’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Buy	+18,600	New	+$398K	﹤0.01%	1286

Other funds holding IMNM

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Maltin Wealth Management Ridgewood, New Jersey $299M AUM 22.87% 1-Year Est. Return

MB, Levis & Associates Center Valley, Pennsylvania $271M AUM 15.56% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

D.A. Davidson & Co's IMNM Position: Q2 2026 in Review

D.A. Davidson & Co opened a new position in Immunome (IMNM) in Q2 2026: 18,600 shares worth $394K. The stake represents ﹤0.01% of the portfolio and ranks #1286 among its holdings.

18 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

D.A. Davidson & Co held 18,600 shares of Immunome worth $394K as of Q2 2026.
Immunome was a new D.A. Davidson & Co position in Q2 2026.
Immunome made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q2 2026, its #1286 holding.
18 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.